F16.95

Clinical Causes: Use of hallucinogenic substances such as LSD, psilocybin (magic mushrooms), mescaline, DMT, or other similar drugs. Genetic predisposition or family history of psychotic disorders. Pre-existing mental health conditions that increase vulnerability to substance-induced psychosis. High doses or frequent use of hallucinogens. Concurrent use of other psychoactive substances, which may exacerbate mental health effects.

Key Symptoms: Auditory or visual hallucinations, often vivid and distressing. Delusional thoughts or beliefs that are not based in reality. Disorganized thinking and incoherent speech. Severe anxiety, paranoia, or suspiciousness. Intense emotional shifts, including euphoria, panic, or depression. Altered perception of time and space, sometimes leading to disorientation. Impulsive or risky behaviors during episodes of psychosis. Sleep disturbances and physical agitation.

Diagnosis Path: Diagnosis involves a comprehensive assessment by a mental health professional, including a detailed history of substance use and mental health evaluations. Medical tests are performed to rule out other potential causes of psychosis. The clinician considers the timing of hallucinations and psychotic features concerning recent hallucinogen use. Additional assessments may include psychological testing and interviews with relatives or caregivers to gather an accurate clinical picture.

Treatment Protocols: Treatment strategies focus on symptom management and stabilizing the individual. Common approaches include: - Discontinuation of hallucinogenic substances. - Use of antipsychotic medications to control hallucinations, delusions, and disorganized thinking. - Supportive psychotherapy to help the individual cope with symptoms and develop healthier coping mechanisms. - Monitoring and managing comorbid conditions such as depression, anxiety, or substance use disorders. - Psychoeducation about the risks associated with hallucinogen use and strategies to prevent future episodes. In some cases, hospitalization may be necessary if symptoms are severe or if there is a risk of self-harm or harm to others. Long-term follow-up is important for recovery and preventing recurrence.